EN PL
ORIGINAL PAPER
Preliminary test of Polish translation of the Rheumatoid and Arthritis Outcome Score – observational study
 
More details
Hide details
1
Department of Orthopedics and Traumatology, Medical University of Warsaw, Poland
 
2
Department of Rehabilitation in Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
 
3
Scientific Association of Reconstructive and Oncology Orthopaedics of the Department of Orthopedics and Traumatology, Medical University of Warsaw, Warsaw, Poland
 
 
Submission date: 2024-03-26
 
 
Final revision date: 2024-05-20
 
 
Acceptance date: 2024-05-23
 
 
Publication date: 2024-07-12
 
 
Corresponding author
Adam Zalewski   

Department of Rehabilitation in Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
 
 
Reumatologia 2024;62(3):157-160
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Today, patients with inflammatory joint diseases participate in more physical activities, including sports and recreation. The tools currently used to assess quality of life and functioning in rheumatic diseases, available in Polish, do not address these problems. The Rheumatoid and Arthritis Outcome Score (RAOS) ques- tionnaire was developed but is not available in the Polish language. This tool is used to evaluate the functional limitations of physically active people who suffer from arthritis and associated lower limb disorders. The objective of this study is the translation and cross-cultural adaptation of the RAOS into Polish.

Material and methods:
The process was carried out following the guidelines of the Evidence-Based Medicine Committee of the American Academy of Orthopaedic Surgeons (AAOS). The translation included forward and back translation, and synthesis of the transcripts. The RAOS was pre-tested in a target setting in 19 patients and final amendments were made to address concerns raised by the patients.

Results:
The translation, adaptation, and pre-test of the Polish RAOS resulted in the final version of the scale, which can be found in Supplementary material 1.

Conclusions:
During pre-testing, the scale demonstrated ease of understanding, with patient feedback leading to minor corrections that were incorporated into the questionnaire structure. Before widespread implementation, a crucial step involves validating the scale through rigorous psychometric tests, including assessments of the reliability, validity and stability of the Polish RAOS. The lack of validation of the translated Polish version limits the use of the RAOS in the research environment. To solve this problem, the validation process is planned to be carried out in the next stage.

 
REFERENCES (17)
1.
Bearne LM. Physical activity in rheumatoid arthritis-is it time to push the pace of change? Rheumatol Adv Pract 2023; 7: rkac107, DOI: 10.1093/rap/rkac107.
 
2.
Wróbel A, Barańska I, Szklarczyk J, et al. Relationship between perceived stress, stress coping strategies, and clinical status in patients with rheumatoid arthritis. Rheumatol Int 2023; 43: 1665–1674, DOI: 10.1007/s00296-023-05367-6.
 
3.
Bączyk G, Kleka P, Ochmańska M. Evaluation psychometric properties of the Polish version Arthritis Impact Measurement Scales (AIMS-2) for patients with rheumatoid arthritis. Rheumatology 2009; 47: 282–289.
 
4.
Bremander AB, Petersson IF, Roos EM. Validation of the Rheumatoid and Arthritis Outcome Score (RAOS) for the lower extremity. Health Qual Life Outcomes 2003; 1: 55, DOI: 10.1186/ 1477-7525-1-55.
 
5.
Roos EM. 30 years with the Knee injury and Osteoarthritis Outcome Score (KOOS). Osteoarthritis Cartilage 2024; 32: 421–429, DOI: 10.1016/j.joca.2023.10.002.
 
6.
Pulik Ł, Romaniuk K, Jaśkiewicz K, et al. An update on joint- specific outcome measures in total hip replacement. Reumatologia 2020; 58: 107–115, DOI: 10.5114/reum.2020.95366.
 
7.
Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000; 25: 3186–3191, DOI: 10.1097/ 00007632-200012150-00014.
 
8.
Comins JD, Brodersen J, Siersma V, et al. How to develop a condition-specific PROM. Scand J Med Sci Sports 2021; 31: 1216–1224, DOI: 10.1111/sms.13868.
 
9.
Negahban H, Masoudpur F, Rajaei E, et al. Reliability, validity, and responsiveness of the Persian version of the rheumatoid and arthritis outcome score (RAOS) in patients with rheumatoid arthritis. Clin Rheumatol 2015; 34: 35–42, DOI: 10.1007/s10067-014-2515-4.
 
10.
Göksel Karatepe A, Günaydin R, Türkmen G, et al. The validity and reliability of the Turkish version of the Rheumatoid and Arthritis Outcome Score (RAOS) in patients with rheumatoid arthritis. Clin Rheumatol 2009; 28: 47–51, DOI: 10.1007/s10067-008-0981-2.
 
11.
Duval A, Maillefert JF, Gossec L, et al. Cross-cultural adaptation and validation of the French version of the Rheumatoid and Arthritis Outcome Score (RAOS). Clin Exp Rheumatol 2010; 28: 806–812.
 
12.
Ben Tekaya A, Ben Dhia S, Hannech E, et al. Foot function in rheumatoid arthritis: correlation between the Rheumatoid and Arthritis Outcome Score and performance-based physical tests. Musculoskeletal Care 2023; 21: 362–371, DOI: 10.1002/msc.1702.
 
13.
Ben Tekaya A, Nouicer S, Salah S, et al. Correlation of impaired foot function with disease activity and structural damage in patients with rheumatoid arthritis. Int J Foot Ankle 2022; 6: 074, DOI: 10.23937/2643-3885/1710074.
 
14.
Malm K, Bergman S, Andersson M, et al. Worse physical function at disease onset predicts a worse outcome in physical function, but not in meeting who physical activity recommendations, nine years later. Ann Rheum Dis 2013; 71 (Suppl 3): 750, DOI: 10.1136/annrheumdis-2012-eular.2934.
 
15.
Rahimi H, Dieudonne G, Kheyfits V, et al. Relationship between lymph node volume and pain following certolizumab therapy for rheumatoid arthritis flare: a pilot study. Clin Med Insights Arthritis Musculoskelet Disord 2016; 9: 203–208, DOI: 10.4137/CMAMD.S40237.
 
16.
Sohrbeck-Nøhr O, Kristensen JH, Boyle E, et al. Generalized joint hypermobility in childhood is a possible risk for the development of joint pain in adolescence: a cohort study. BMC Pediatr 2014; 14: 302, DOI: 10.1186/s12887-014-0302-7.
 
17.
Ghassemi Jahani SA, Karlsson J, Brisby H, et al. Health-related quality of life and function in middle-aged individuals with thalidomide embryopathy. J Child Orthop 2016; 10: 691–703, DOI: 10.1007/s11832-016-0797-6.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top